A comparative study of two treatment schemes in clinical sinusitis.
D000328:Adult; D000814:Aniline Compounds / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D001826:Body Fluids / Q000382:microbiology; D003510:Cyclohexanes / Q000627:therapeutic use; D004357:Drug Synergism; D005029:Ethylenediamines / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005100:Expectorants / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009666:Nose; D010402:Penicillin G Procaine / Q000627:therapeutic use; D010946:Plants, Medicinal; D011725:Pyridines / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D044469:Racial Groups; D012852:Sinusitis / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors
D000814:Aniline Compounds; D001593:Benzyl Compounds; D003510:Cyclohexanes; D005029:Ethylenediamines; D005100:Expectorants; D006634:Histamine H1 Antagonists; D011725:Pyridines; D000644:Quaternary Ammonium Compounds; D010402:Penicillin G Procaine; D013307:Streptomycin